Results 191 to 200 of about 3,836,064 (302)

Conversion between the Brief assessment of Impaired Cognition, Brief Assessment of Impaired Cognition Questionnaire, and Mini-Mental State Examination in a mixed clinical sample. [PDF]

Neurol Sci
Jørgensen K, Nielsen TR, Kjaergaard D, Waldorff FB, Nielsen A, Nørgaard A, Salem LC, Langkilde TRR, Waldemar G.   +8 more
europepmc   +1 more source

Pharmacological chromatin remodeling enhances response to estrogen therapy in ER+ breast cancer

Molecular Oncology, EarlyView.
Estrogen therapy elicits clinical benefit in ~ 30% of patients with endocrine‐resistant estrogen receptor (ER)‐positive breast cancer. Based on findings that ER transcriptional activation underlies response to estrogen therapy, we tested the effects of epigenetic dysregulation via pharmacological inhibition of histone deacetylases (HDACi).
Anneka L. Johnson Thomas, Barbara Karakyriakou, Patricia C. Muskus, Alyssa M. Roberts, Justin Rendleman, Alexa Warren, Hanxu Lu, Kimberly A. Birmingham, Malone K. Friedman, Abigail E. Goen, Huijuan Yang, Owen M. Wilkins, Fred W. Kolling, Eugene Demidenko, Julie M. Jorns, Brock C. Christensen, Todd W. Miller   +16 more
wiley   +1 more source

Bringing Regulatory-Style Benefit-Risk Assessment to the Bedside: A Structured Evidence Synthesis Methodology for Shared Decision-Making. [PDF]

J Eval Clin Pract
Garcia-Zamora S, Tavares-Da-Silva F, Labudovic I, Vicco MH.   +3 more
europepmc   +1 more source

PANoptosis in the pathogenesis of myelodysplastic syndromes

Molecular Oncology, EarlyView.
PANoptosis, a combination of three types of programmed cell death, is mediated by a large protein complex called a PANoptosome. In healthy bone marrow hematopoietic cells, PANoptosis is restricted by inhibitory signaling. In MDS, bone marrow cells become sensitive to the PANoptotic stimuli due to the aberrant inactivation of inhibitory signaling or ...
Rohit Thalla, Jyoti Lamichhane, Cameron Lewis, Peter Breslin, Jiwang Zhang   +4 more
wiley   +1 more source

2026-2027 AAFP Immunization Schedules: What's New and Why It Matters For Family Medicine. [PDF]

Ann Fam Med
Savoy M.
europepmc   +1 more source

Spatial biology in cancer epigenetics

Molecular Oncology, EarlyView.
Spatial epigenomics combines molecular profiling with tissue architecture to reveal how gene regulation is organized within intact tissues. In cancer, these technologies uncover the mechanisms driving tumor heterogeneity and microenvironmental interactions, opening new opportunities for biomarker discovery and precision medicine.
Eva Crespo‐García, Manel Esteller
wiley   +1 more source

Retraction of "Discoloration of teeth due to different intracanal medicaments" published in Restorative Dentistry and Endodontics. [PDF]

Restor Dent Endod
europepmc   +1 more source

Coagulopathy in Critically Ill Patients With Sepsis: Protocol for a Scoping Review. [PDF]

Acta Anaesthesiol Scand
Andersen CHS, Hansen JD, Hvas CL, Møller K, Gradel KO, Møller AM, Russell L.   +6 more
europepmc   +1 more source

Intrapatient tumour heterogeneity and clonal evolution in an autopsy study of metastatic salivary gland cancer

Molecular Oncology, EarlyView.
Tumour heterogeneity and clonal evolution of metastatic salivary gland cancer were evaluated in two patients with adenoid carcinoma and one patient with myoepithelial carcinoma. Radiology‐guided autopsy enabled multi‐region sampling (total samples n = 149), followed by whole‐genome sequencing and phylogenetic reconstruction (17 tumour samples, 4–7 per ...
Gerben Lassche, Niels J. van Ruitenbeek, Charlotte Adang, Luke O'Gorman, Pui Yuen Lee, Willemijn M. Klein, Adriana C. H. van Engen‐van Grunsven, Jack A. Schalken, Sander Bervoets, Gerald W. Verhaegh, Carla M. L. van Herpen   +10 more
wiley   +1 more source

Decision Tree Model for Predicting the Overall Survival of Endometrial Cancer Patients with Adenomyosis. [PDF]

Int J Womens Health
Cecen Donmez Y, Keles E, Şanlıkan F, Kara SS, Baglar I, Demirden A, Durmus S, Uzun H, Erkok U.   +8 more
europepmc   +1 more source